6 Phase II, multi-centre, dose-escalating study of LB80380 (ANA380) in hepatitis B patients with lamivudine-resistant YMDD mutant HBV

✍ Scribed by C.L. Lai; K.H. Han; S.K. Yoon; S.H. Um; M.F. Yuen; H.S. Kim; H.R. Kim; H.C. Chung; C.R. Kim; P. Hsyu; D. Averett; S. Worland; J. Kim

• Book ID: 117374289
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 101 KB
• Volume: 44
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/s0168-8278(06)80007-3